In the present study, we investigated the mechanism of HOXA10 regarding its role in temozolomide resistance using glioblastoma cell lines and tested the therapeutic implication of temozolomide resistance in conjunction with MGMT status. The gene discussed is HOXA10; the disease is glioblastoma.